US tariff heat: Fitch says Indian firms face limited direct hit; pharma sector seen at risk if duties widen
India-based corporates have limited direct exposure to US tariffs, but sectors such as pharmaceuticals that are currently unaffected could face risks if Washington announces further measures, Fitch Ratings has cautioned.The US has imposed a 25% “reciprocal” tariff on Indian goods from August 7, 2025, and an additional 25% levy will take effect on August 27, […]